சோதனைகள் ஆராய்ச்சி கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NVT Hong Kong – July 20th , 2021 – Novotech Health Holdings Pte. Ltd. (“Novotech”) joins a historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The “Decentralized Trials & Research Alliance ,” which was launched in December, 2020, is uniting industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research. “We are excited to join the DTRA and help accelerate the development of virtual trials in the Asia-Pacific region,” said Dr John Moller, CEO at Novotech. “Virtual trials offer patients greater access to the important clinical trials conducted across our region”, he added.

United statesHong kongAmir kalaliCraig lipsetJohn mollerTrials research allianceNovotech health holdings pteNovotech health holdingsResearch allianceDecentralized trialsஒன்றுபட்டது மாநிலங்களில்ஹாங் காங்அமீர் கலாலிஜான் மாலர்சோதனைகள் ஆராய்ச்சி கூட்டணிஆராய்ச்சி கூட்டணி